Thursday, June 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of California”

3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,494
Index total 30,257
Page 59 / 146

Quick answer

This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,494 results for “The Regents of the University of California” · 30,257 patents in full index Clear search

  1. US 9889071

    Calcium sulfate-resin hybrid materials and methods of using and making the same

    The Regents of the University of California · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  2. US 9884070

    Selective high-affinity polydentate ligands and methods of making such

    The Regents of the University of California · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

  3. US 9885014

    Re-conditioned serum-free culture medium composition obtained by culturing mammalian cells in Fibromodulin

    The Regents of the University of California · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

  4. US 9878006

    Treatment of obesity and obesity related disorders by pharmalogical targeting of Kv1.3 potassium channels

    The Regents of the University of California · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  5. US 9878033

    Immunogenic peptides for treatment of herpes simplex virus infection and conditions

    The Regents of the University of California · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  6. US 9878137

    Bioactive agent delivery devices and methods of making and using the same

    The Regents of the University of California · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  7. US 9873718

    Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics

    The Regents of the University of California · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted

  8. US 9868961

    Methods and compositions for localized secretion of anti-CTLA-4 antibodies

    The Regents of the University of California · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  9. US 9867845

    Vectors for delivery of agents across biological membranes

    The Regents of the University of California · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  10. US 9867778

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  11. US 9862684

    Modulation of K2P channels

    The Regents of the University of California · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  12. US 9862693

    Compounds and methods of treating cancer

    The Regents of the University of California · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  13. US 9855368

    Bone morphogenic protein binding peptide

    The Regents of the University of California · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  14. US 9856273

    ETP derivatives

    The Regents of the University of California · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  15. US 9856283

    Thiosaccharide mucolytic agents

    The Regents of the University of California · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  16. US 9856539

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  17. US 9848853

    System, method and devices for tissue-based diagnosis

    The Regents of the University of California · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

  18. US 9850207

    Substituted piperidines as soluble epdxide hydrolase inhibitors

    The Regents of the University of California · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

  19. US 9845357

    Integrin αvβ8 neutralizing antibody

    The Regents of the University of California · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

  20. US 9844657

    Compositions comprising nanostructures for cell, tissue and artificial organ growth, and methods for making and using same

    The Regents of the University of California · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

  21. US 9845237

    Supramolecular approach for preparation of size controllable nanoparticles

    The Regents of the University of California · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

  22. US 9844656

    Localization of agents at a target site with a composition and an energy source

    The Regents of the University of California · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

  23. US 9840470

    Targeting GLI proteins in human cancer by small molecules

    The Regents of the University of California · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted

  24. US 9840483

    Radiomitigating pharmaceutical formulations

    The Regents of the University of California · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.